By stimulating tumor angiogenesis/lymphangiogenesis, the proliferation and migration of endothelial cells, and the vasodilator effect, CGRP participates in the growth and survival of tumor cells, and the administration of antagonists reduces the expression of VEGF and the formation of new vessels [8,20,29,35,40]. The gene discussed is CALCA; the disease is neoplasm.